Effective alternates to trimethoprim-sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: are there any?
Ramesh
Mayur
M
Chandrasekar
Pranatharthi H
PH
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D015195:Drug Design; D006086:Graft vs Host Disease / Q000517:prevention & control; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D016377:Organ Transplantation / Q000379:methods*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D033581:Stem Cell Transplantation / Q000379:methods*; D014123:Toxoplasmosis / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination